We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
GSK plc | NYSE:GSK | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.20 | 0.49% | 41.11 | 41.3125 | 40.87 | 40.95 | 2,730,464 | 01:00:00 |
--South Africa's Competition Commission gave conditional approval to a proposed joint venture between pharmaceutical companies GlaxoSmithKline PLC (GSK) and Pfizer Inc. (PFE), Reuters reported Tuesday.
--The Commission suggested the JV continue to use South African manufacturer and packager Spechparm Holdings for three years, in an effort to alleviate the impact of the deal on local companies working for Pfizer, the report said.
Full story: https://www.reuters.com/article/us-pfizer-gsk-jointventure/gsk-pfizer-joint-venture-gets-conditional-approval-from-south-africas-competition-regulator-idUSKCN1TX1MR
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
July 02, 2019 13:55 ET (17:55 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions